Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 8.0B | 9.3B | 8.3B | 6.4B |
Cost of revenue | 5.5B | 6.8B | 6.5B | 5.8B |
Gross profit | 2.6B | 2.5B | 1.8B | 647M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 241M | 264M | 283M | 294M |
Other operating expenses | 300M | 272M | 268M | 280M |
Operating income | 976M | 2.0B | 1.3B | 73M |
Non operating interest income | ||||
Income | 105M | 112M | 112M | 75M |
Expense | 225M | 206M | 243M | 228M |
Other income expense | — | — | — | — |
Pretax income | 608M | 1.9B | 1.1B | -87M |
Tax provision | 216M | 474M | 224M | -83M |
Net income | 392M | 1.4B | 909M | -4M |
Basic EPS | — | 0.3 | 0.2 | 0.0 |
Diluted EPS | — | 0.3 | 0.2 | 0.0 |
Basic average shares | — | 5.7B | 5.8B | 4.7B |
Diluted average shares | — | 5.7B | 5.8B | 4.7B |
EBITDA | 907M | 2.2B | 1.4B | 151M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |